Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Alendronate versus alfacalcidol (1-alpha OH vitamin D)
(D01518)		[3] Alendronic acid,
Alfacalcidol,
Vitamin D		[2] Alfacalcidol (D01518),
Alendronic acid 💬		[2] FDPS,
VDR 💬		[9] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Terpenoid backbone biosynthesis, Tuberculosis 💬[3] 41, 46, 50 💬
2ALFACALCIDOL
(D01518)		[1] Alfacalcidol[1] Alfacalcidol (D01518) 💬[1] VDR 💬[5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[8] 41, 46, 49, 50, 96, 107, 235, 238 💬
3Alfacalcidol 2 micrograms/ml
(D01518)		[1] Alfacalcidol[1] Alfacalcidol (D01518) 💬[1] VDR 💬[5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[2] 50, 107 💬
4Ibandronate+alfacalcidol+calcium
(D01518)		[3] Alfacalcidol,
Calcium,
Ibandronate		[1] Alfacalcidol (D01518) 💬[1] VDR 💬[5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[1] 49 💬